You will find individual care pathways for sufferers with a class A and course B CPS and for people with a category C CPS. In addition, the authors present an algorithmic approach to these agents during the transplant inhabitants, specializing in to start with line usage of glucagon-like peptide one (GLP-1) agonists due to their further Positive as